Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AMRN – Amarin Corp ADR

Amarin Corporation plc
AMRN
$19.29
Name : Amarin Corporation plc
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $398,970,752.00
EPSttm : -5
finviz dynamic chart for AMRN
Amarin Corporation plc
$19.29
0.21%
$0.04

Float Short %

1.96

Margin Of Safety %

Put/Call OI Ratio

0.58

EPS Next Q Diff

-0.09

EPS Last/This Y

4.2

EPS This/Next Y

-0.05

Price

19.3

Target Price

11

Analyst Recom

4.33

Performance Q

14.85

Relative Volume

3.65

Beta

0.68

Ticker: AMRN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-09-08AMRN14.760.290.159358
2025-09-09AMRN15.260.290.219417
2025-09-10AMRN15.060.283.139510
2025-09-11AMRN14.950.280.489537
2025-09-12AMRN150.280.809560
2025-09-15AMRN14.890.290.169567
2025-09-16AMRN14.950.291.189472
2025-09-17AMRN14.60.294109626397612.489491
2025-09-18AMRN14.920.340.109825
2025-09-19AMRN15.290.330.419838
2025-09-22AMRN15.360.900.063850
2025-09-23AMRN15.370.740.174613
2025-09-24AMRN15.40.730.204701
2025-09-25AMRN15.440.710.604804
2025-09-26AMRN160.721.004860
2025-09-29AMRN16.060.690.534826
2025-09-30AMRN16.380.700.084920
2025-10-01AMRN16.60.680.075011
2025-10-02AMRN16.760.643.005257
2025-10-03AMRN18.840.640.055265
2025-10-06AMRN19.190.580.195691
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-09-08AMRN14.77100.0- 0.20
2025-09-09AMRN15.20100.0- 0.20
2025-09-10AMRN15.06100.0- 0.20
2025-09-11AMRN14.97100.0- 0.20
2025-09-12AMRN15.00100.0- 0.20
2025-09-15AMRN14.93100.0- 0.20
2025-09-16AMRN14.93100.0- 0.20
2025-09-17AMRN14.62100.0- 0.20
2025-09-18AMRN14.89100.0- 0.20
2025-09-19AMRN15.34100.0- 0.20
2025-09-22AMRN15.38100.0- 0.20
2025-09-23AMRN15.35100.0- 0.20
2025-09-24AMRN15.44100.0- 0.20
2025-09-25AMRN15.45100.0- 0.20
2025-09-26AMRN16.00100.0- 0.20
2025-09-29AMRN16.08100.0- 0.20
2025-09-30AMRN16.40100.0- 0.20
2025-10-01AMRN16.61100.0- 0.20
2025-10-02AMRN16.81100.0- 0.20
2025-10-03AMRN18.85100.0- 0.20
2025-10-06AMRN19.30100.0- 0.20
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-09-08AMRN0.001.132.06
2025-09-09AMRN0.001.132.06
2025-09-10AMRN0.001.132.06
2025-09-11AMRN0.001.132.06
2025-09-12AMRN0.001.132.06
2025-09-15AMRN0.002.532.06
2025-09-16AMRN0.002.532.06
2025-09-17AMRN0.002.532.06
2025-09-18AMRN0.002.532.06
2025-09-19AMRN0.002.532.06
2025-09-22AMRN0.002.492.06
2025-09-23AMRN0.002.492.06
2025-09-24AMRN0.002.492.06
2025-09-25AMRN0.002.491.96
2025-09-26AMRN0.002.491.96
2025-09-29AMRN0.002.491.96
2025-09-30AMRN0.002.491.96
2025-10-01AMRN0.002.491.96
2025-10-02AMRN0.002.491.96
2025-10-03AMRN0.002.491.96
2025-10-06AMRN0.000.391.96
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.03

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

-0.12

Insider Transactions

Institutional Transactions

0.39

Beta

0.68

Average Sales Estimate Current Quarter

42

Average Sales Estimate Next Quarter

41

Fair Value

Quality Score

33

Growth Score

24

Sentiment Score

91

Actual DrawDown %

89.6

Max Drawdown 5-Year %

-95.5

Target Price

11

P/E

Forward P/E

PEG

P/S

1.82

P/B

0.86

P/Free Cash Flow

EPS

-5.03

Average EPS Est. Cur. Y​

0.2

EPS Next Y. (Est.)

0.15

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-47.05

Relative Volume

3.65

Return on Equity vs Sector %

-47.4

Return on Equity vs Industry %

-55.9

EPS 1 7Days Diff

2.2

EPS 1 30Days Diff

2.21

EBIT Estimation

Amarin Corporation plc
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 275
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.
stock quote shares AMRN – Amarin Corp ADR Stock Price stock today
news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch AMRN – Amarin Corp ADR yahoo finance google finance
stock history AMRN – Amarin Corp ADR invest stock market
stock prices AMRN premarket after hours
ticker AMRN fair value insiders trading